Drug firms 'invent disease' to boost profits
A new report has accused pharmaceutical companies of hyping up diseases in an attempt to sell more drugs and boost profits.
Archives for April 10, 2006
Olympus unveils next-gen in vivo imaging system
Olympus has unveiled a working concept of what is claimed is the next generation in fluorescence in vivo imaging systems by enabling time-lapse and live imaging of emitted light from labelled processes and tissues.
Icon Clinical Research cements itself in Italy
The growth spurt continues for Icon Clinical Research as it opens up a new office in Milan, Italy, following a recent acquisition and two new global contracts.
VASTox initiates fifth drug discovery cancer programme
VASTox has initiated a fifth drug discovery programme for cancer focusing on a crucial pathway that is active in the developing embryo when cells are required to constantly grow and differentiate. The pathway has been identified as a viable drug target.
Beckman's latest antibody aids cancer research
Beckman Coulter launches its latest monoclonal antibody that identifies Tolereogenic cells making it highly in transplant and cancer research. It is also applicable in clinical research on autoimmunity.
Watson pulls out of injectables manufacturing
Watson Pharmaceuticals is selling its unprofitable injectables manufacturing plant and pulling out of this market segment altogether. The Company is now establishing contract manufacturing agreements to take over the 15 products affected.
Melbourn Scientific undergo major expansion plans
Melbourn Scientific, report an eventful month in which the expansion of its range of services has resulted in the purchase of new premises, as well as meeting requirements of good manufacturing practice that regulate the manufacture and testing of...